Search results
Results from the WOW.Com Content Network
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009.
In 1993, Francis joined Genentech, Inc., of South San Francisco to try to develop a vaccine for HIV. In 1995, Francis and fellow retro-virologist Dr. Robert Nowinski spun off Genentech's HIV vaccine unit after the company had disappointing results, and founded VaxGen, based in Brisbane, California, to continue working on vaccines. After the ...
AIDSVAX is an experimental HIV vaccine that was developed originally at Genentech in San Francisco, California, and later tested by the VaxGen company, a Genentech offshoot. [1] The development and trials of the vaccine received significant coverage in the international media, but American trials proved inconclusive.
Genentech previously said the use of the drug in the indication accounts for a fraction of its overall revenue. The U.S. Food and Drug Administration had granted accelerated approval to Gavreto in ...
Genentech had been able to manufacture, receive federal approval for, and market its own product, marking the successful execution of Swanson's plan to form out of Genentech a self sustainable biotech firm. [5] [6] [8] Swanson left his position as CEO in 1990, taking on the position of chairman until his retirement from Genentech in 1996. [5 ...
The implant was approved by the U.S. health regulator in 2021 to treat a chronic disorder that caused blurred vision. The following year, Genentech voluntarily recalled the implant following test ...
The video showed a body, which the couple said appeared to have deteriorated. Someone off-screen said to the couple, “Hey, no pictures. This is a crime scene.”
The Cabilly patents are two US patents issued to Genentech and City of Hope which relate to the "fundamental technology required for the artificial synthesis of antibody molecules." [ 1 ] The name refers to lead inventor Shmuel Cabilly, who was awarded the patent while working at City of Hope in the 1980s. [ 2 ]